Patents by Inventor Seong Yun Jeong

Seong Yun Jeong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11982705
    Abstract: A substrate analysis apparatus is provided. The substrate analysis includes: an interlayer conveying module configured to transport a first FOUP; an exchange module which is connected to the interlayer conveying module, and configured to transfer a wafer from the first FOUP to a second FOUP; a pre-processing module configured to form a test wafer piece using the wafer inside the second FOUP; an analysis module configured to analyze the test wafer piece; and a transfer rail configured to transport the second FOUP containing the wafer and a tray containing the test wafer piece. The wafer includes a first identifier indicating information corresponding to the wafer, the test wafer piece includes a second identifier indicating information generated by the pre-processing module which corresponds to the test wafer piece, and the analysis module is configured to analyze the first identifier and the second identifier in connection with each other.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: May 14, 2024
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Youn Gon Oh, Ji Hun Kim, Sae Yun Ko, Gil Ho Gu, Dong Su Kim, Eun Hee Lee, Ho Chan Lee, Seong Sil Jeong, Seong Pyo Hong
  • Patent number: 11949746
    Abstract: Provided are an IoT device and an IoT communication method. The IoT device may: be connected to a server via NAT; execute a first session for service connection; and execute a second session for calculating a particular keep-alive value corresponding to a period in which an IP address mapped by the NAT expires. The present invention can minimize transmission of a keep-alive value of an IoT device, enables an IoT device to share a particular keep-alive value with other IoT devices, and thus can minimize a network load which may be caused by a keep-alive value of an IoT communication device.
    Type: Grant
    Filed: November 20, 2019
    Date of Patent: April 2, 2024
    Assignee: KOREA ELECTRONICS TECHNOLOGY INSTITUTE
    Inventors: Seong Yun Kim, Seung Myeong Jeong, Ji Ho Lee
  • Patent number: 11674184
    Abstract: The present invention relates to a biomarker composition for diagnosing radiation-resistant cancer comprising PMVK as an active ingredient and a method of diagnosing radiation-resistant cancer using the same, and when the PMVK is knocked down, it is confirmed that the survival rate of cancer cells decreases during radiation treatment, and based on this, the possibility as a factor related to radiation therapy resistance to cancer was suggested, and the PMVK can be used as a new target to enhance the effect of radiation therapy on human cancer cells.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: June 13, 2023
    Assignee: ENHANCEDBIO INC.
    Inventors: Eun Kyung Choi, Seong-Yun Jeong, Si Yeol Song, Yun-Yong Park, Seok Soon Park, Eun Jin Ju, Eun Jung Ko
  • Patent number: 11046779
    Abstract: The present invention provides antibodies which specifically bind to pancreatic adenocarcinoma upregulated factor (PAUF) protein and uses thereof.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: June 29, 2021
    Assignees: DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION, PRESTIGE BIOPHARMA PTE. LTD.
    Inventors: Sang Seok Koh, Yeon Jeong Kim, So Eun Youn, Song Cheol Kim, Seung-Mo Hong, Seong Yun Jeong
  • Publication number: 20210025007
    Abstract: The present invention relates to a biomarker composition for diagnosing radiation-resistant cancer comprising PMVK as an active ingredient and a method of diagnosing radiation-resistant cancer using the same, and when the PMVK is knocked down, it is confirmed that the survival rate of cancer cells decreases during radiation treatment, and based on this, the possibility as a factor related to radiation therapy resistance to cancer was suggested, and the PMVK can be used as a new target to enhance the effect of radiation therapy on human cancer cells.
    Type: Application
    Filed: November 21, 2018
    Publication date: January 28, 2021
    Applicant: ENHANCEDBIO INC.
    Inventors: Eun Kyung CHOI, Seong-Yun JEONG, Si Yeol SONG, Yun-Yong PARK, Seok Soon PARK, Eun Jin JU, Eun Jung KO
  • Patent number: 10627402
    Abstract: Provided is a peptide for targeting gastric cancer, a composition for diagnosing radioresponsiveness-dependent gastric cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: April 21, 2020
    Assignee: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Eun Kyung Choi, Seong-Yun Jeong, Si Yeol Song, Kyoung Jin Lee, Seol Hwa Shin, Eun Jin Ju
  • Publication number: 20200055951
    Abstract: The present invention relates to an antibody specifically binding to a pancreatic adenocarcinoma upregulated factor (PAUF) protein and use thereof. The antibody of the present invention binds to a PAUF protein with high specificity and affinity and thereby inhibits the proliferation, migration, invasion, and in vivo growth, and thus the antibody of the present invention can be effectively used in the field of diagnosis and treatment of diseases such as cancer in which PAUF proteins are overexpressed.
    Type: Application
    Filed: August 16, 2017
    Publication date: February 20, 2020
    Applicants: DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION, PRESTIGE BIOPHARMA PTE. LTD.
    Inventors: Sang Seok KOH, Yeon Jeong KIM, So Eun YOUN, Song Cheol KIM, Seung-Mo HONG, Seong Yun JEONG
  • Patent number: 10393744
    Abstract: Provided is a peptide for targeting colorectal cancer, a composition for diagnosing radioresponsiveness-dependent prognosis of colorectal cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, in consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: August 27, 2019
    Assignee: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Eun Kyung Choi, Seong-Yun Jeong, Si Yeol Song, Kyoung Jin Lee, Jinhyang Choi, Jaesook Park, Seok Soon Park, Jae Hee Lee
  • Publication number: 20190203302
    Abstract: The present invention relates to a biomarker composition for diagnosing radiation-resistant cancer comprising LRP-1 as an active ingredient and a method of diagnosing radiation-resistant cancer using the same, and identifies LRP-1 which a binding partner protein to which specific peptide sequences specifically targeting radiation-resistant colon cancer tissues are actually bound, and based on this, suggests the possibility of radiation therapy resistance factor for cancer.
    Type: Application
    Filed: May 16, 2017
    Publication date: July 4, 2019
    Applicants: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION, THE ASAN FOUNDATION
    Inventors: Eun Kyung CHOI, Seong-Yun JEONG, Si Yeol SONG, Kyoung Jin LEE
  • Publication number: 20190018014
    Abstract: Provided is a peptide for targeting gastric cancer, a composition for diagnosing radioresponsiveness-dependent gastric cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
    Type: Application
    Filed: October 2, 2018
    Publication date: January 17, 2019
    Applicant: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Eun Kyung CHOI, Seong-Yun JEONG, Si Yeol SONG, Kyoung Jin LEE, Seol Hwa SHIN, Eun Jin JU
  • Publication number: 20170328906
    Abstract: Provided is a peptide for targeting colorectal cancer, a composition for diagnosing radioresponsiveness-dependent prognosis of colorectal cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, in consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
    Type: Application
    Filed: July 29, 2015
    Publication date: November 16, 2017
    Applicant: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Eun Kyung CHOI, Seong-Yun JEONG, Si Yeol SONG, Kyoung Jin LEE, Jinhyang CHOI, Jaesook PARK, Seok Soon PARK, Jae Hee LEE
  • Publication number: 20170322213
    Abstract: Provided is a peptide for targeting gastric cancer, a composition for diagnosing radioresponsiveness-dependent gastric cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
    Type: Application
    Filed: July 29, 2015
    Publication date: November 9, 2017
    Applicant: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Eun Kyung CHOI, Seong-Yun JEONG, Si Yeol SONG, Kyoung Jin LEE, Seol Hwa SHIN, Eun Jin JU
  • Patent number: 9173841
    Abstract: The present invention relates to a polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, and more specifically, to an injection formulation composition containing rapamycin wherein water solubility is improved by solubilizing rapamycin having low water solubility with polymer nanoparticles, a preparation method thereof, and an anticancer composition for a combined use with radiotherapy.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: November 3, 2015
    Assignee: SAMYANG BIOPHARMACEUTICALS CORPORATION
    Inventors: Hye Won Kang, Min Hyo Seo, Sa Won Lee, Bong Oh Kim, Eun Kyung Choi, Seong Yun Jeong, Ha Na Woo
  • Publication number: 20140212462
    Abstract: The present invention relates to a polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, and more specifically, to an injection formulation composition containing rapamycin wherein water solubility is improved by solubilizing rapamycin having low water solubility with polymer nanoparticles, a preparation method thereof, and an anticancer composition for a combined use with radiotherapy.
    Type: Application
    Filed: March 31, 2014
    Publication date: July 31, 2014
    Applicant: SAMYANG BIOPHARMECEUTICALS CORPORATION
    Inventors: Hye Won KANG, Min Hyo SEO, Sa Won LEE, Bong Oh KIM, Eun Kyung CHOI, Seong Yun JEONG, Ha Na WOO
  • Publication number: 20120276169
    Abstract: The present invention relates to a polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, and more specifically, to an injection formulation composition containing rapamycin wherein water solubility is improved by solubilizing rapamycin having low water solubility with polymer nanoparticles, a preparation method thereof, and an anticancer composition for a combined use with radiotherapy.
    Type: Application
    Filed: December 29, 2010
    Publication date: November 1, 2012
    Inventors: Hye Won Kang, Min Hyo Seo, Sa Won Lee, Bong Oh Kim, Eun Kyung Choi, Seong Yun Jeong, Ha Na Woo
  • Patent number: 7593310
    Abstract: The present invention relates to a method of manufacturing a multilayered disk capable of refraining from an interference at the adjacent layer when a specific layer of the multilayered layers is recorded or regenerated in an optical disk. According to the present invention, a method for manufacturing a multilayered disk having at least two recording layers is characterized by that a space between the two recoding layers is set to less than 10 ?m to refrain from an interference at the adjacent layer when one of the recording layers is recorded or regenerated. According to a method for manufacturing a multilayered disk and a method for removing an interlayer interference using the disk in the present invention, it is possible to design and manufacture a multilayered disk within a reflective signal range.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: September 22, 2009
    Assignee: LG Electronics Inc.
    Inventor: Seong-Yun Jeong
  • Patent number: 7248372
    Abstract: The disclosure includes a system, device, apparatus and programmed medium of measuring thickness of an optical disc by using an interference effect of the optical disc layer. Such a system can include: a spectroscope to separate light, reflected from a surface of an optical disc, into constituent frequencies thereof; an optical intensity measuring unit to measure intensities of the constituent frequencies, respectively, as a first spectrum of data; and a processor to do at least the following, convert the first spectrum data into a second spectrum of values that exhibits variation as a function wavelength and refractive index, transform the second spectrum using a Fast Fourier Transform, and detect a thickness of one or more of the spacer layer and the cover layer, respectively, based upon the transformed spectrum. The disclosed technologies have advantages for high precisely measuring thickness of an optical disc.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: July 24, 2007
    Assignee: LG Electronics, Inc.
    Inventors: Seong Yun Jeong, Jin Yong Kim, Jin Hong Kim, Hun Seo, Keum Cheol Kwak
  • Patent number: 7197002
    Abstract: An optical pickup apparatus and an optical recording/reproducing apparatus employing the optical pickup apparatus, which can be adaptive for multiple types of optical discs different in the layout conditions such as recording density, etc., are provided. The optical pickup includes an optical pickup for accessing at least first and second optical recording mediums, the pickup comprising a first light source generating a first light beam of a first wavelength; a second light source generating a second light beam of a second wavelength different from the first wavelength; an optical section transmitting the first and second light beams; and an aperture number controller including a wave selecting member for selecting between the first and second light beams of different wavelengths so as to impinge a light beam with an appropriate aperture number to selectively access one of the at least first and second optical recording mediums.
    Type: Grant
    Filed: November 5, 2004
    Date of Patent: March 27, 2007
    Assignee: LG Electronics Inc.
    Inventors: Jin Yong Kim, Seong Yun Jeong
  • Patent number: 7145662
    Abstract: A method of measuring thickness of an optical disc by using an interference effect of the optical disc layer is disclosed. The method includes detecting an intensity of a reflective light according to a wavelength of a light as spectrum data for each wavelength, converting the detected spectrum data for each wavelength into a spectrum value as a function of a wavelength that a refractive index is reflected, and detecting a position where the intensity of the reflective light has a peak as a thickness of a spacer layer and a cover layer respectively by converting the converted value into a length of an interference area for representing a layer thickness of the optical disc by the Fast Fourier Transform. The disclosed method has advantages for high precisely measuring thickness of an optical disc.
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: December 5, 2006
    Assignee: LG Electronics, Inc.
    Inventors: Seong Yun Jeong, Jin Yong Kim, Jin Hong Kim, Hun Seo, Keum Cheol Kwak
  • Publication number: 20060256704
    Abstract: The present invention relates to a method of manufacturing a multilayered disk capable of refraining from an interference at the adjacent layer when a specific layer of the multilayered layers is recorded or regenerated in an optical disk. According to the present invention, a method for manufacturing a multilayered disk having at least two recording layers is characterized by that a space between the two recoding layers is set to less than 10 ?m to refrain from an interference at the adjacent layer when one of the recording layers is recorded or regenerated. According to a method for manufacturing a multilayered disk and a method for removing an interlayer interference using the disk in the present invention, it is possible to design and manufacture a multilayered disk within a reflective signal range.
    Type: Application
    Filed: April 18, 2006
    Publication date: November 16, 2006
    Applicant: LG Electronics Inc.
    Inventor: Seong-Yun Jeong